HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal My Folders Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Bothe, A. K. Articles by Davidow, J. H. Search for Related Content PubMed Articles by Bothe, A. K. Articles by Davidow, J. H.

Pharmacological Approaches to Stuttering Treatment: Reply to Meline and Harn (2008)

Roger J. Ingham
University of California, Santa Barbara

Jason H. Davidow
Hofstra University, Hempstead, NY

Contact author: Anne K. Bothe, Department of Communication Sciences and Special Education, 516 Aderhold Hall, The University of Georgia, Athens, GA 30602. E-mail: abothe{at}uga.edu.

Purpose: To address questions raised by T. Meline and W. E. Harn (2008) in their critique of our previous article (A. K. Bothe, J. H. Davidow, R. E. Bramlett, D. M. Franic, & R. J. Ingham, 2006).

Method: Additional information is provided to address several issues raised by Meline and Harn.

Results and Conclusions: Our previous systematic review omitted 1 relevant article about the use of olanzapine in stuttering, but the minimal effectiveness and the known serious side effects of this drug limit the implications of this omission. While we do not agree with many of Meline and Harn's critiques of our review, we do agree with them that several larger points raise interesting questions about the structure, analysis, and usefulness of literature reviews in stuttering and in other areas. Fundamentally, we reassert our agreement with Meline and Harn that there is insufficient evidence to support the use of existing pharmacological agents in the treatment of stuttering.

Key Words: stuttering, olanzapine, systematic review